ABBV-1042 Clinical Trials (2026): 1 Studies for Healthy Volunteer
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 ABBV-1042 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Healthy Volunteer) and 48 total planned enrollment. Most recent activity: NCT07222709 (Sep 2026).
ABBV-1042 clinical trials at a glance: phase × recruitment status
| Phase | active not recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
All ABBV-1042 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07222709 | A Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participants | P1 | active not recruiting | 48 | AbbVie | Oct 2025 |
ABBV-1042 clinical trials: frequently asked questions
- How many ABBV-1042 clinical trials are there?
- 1 ABBV-1042 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov.
- Are ABBV-1042 clinical trials recruiting in 2026?
- No active ABBV-1042 trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is ABBV-1042 being studied for?
- ABBV-1042 is being studied for Healthy Volunteer. The trials are grouped by indication on this page.
- What phase is ABBV-1042 in?
- ABBV-1042 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors ABBV-1042 clinical trials?
- The lead sponsor across the most ABBV-1042 trials is AbbVie. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming ABBV-1042as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: